Phesgo Injection, Solution
Product Images NDC 50242-260

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Phesgo (NDC 50242-260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (20 mL Vial Carton)

Principal Display Panel (20 mL Vial Carton)
Phesgo is a medication that comes in a single-dose vial for subcutaneous injection over eight minutes. It contains pertuzumab, trastuzumab, and hyaluronidase-zzxf. The NDC number is 50242-245-01, and it is manufactured by Genentech. Any unused portions should be discarded.*
FDA Label Image

Principal Display Panel (15 mL Vial Carton)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.